Results 211 to 220 of about 786,116 (332)
Thrombin and plasmin activity and platelet activation in the development of venous thrombosis [PDF]
J Owen+4 more
openalex +1 more source
Research and scholarly methods: Mitigating information bias
Abstract Whether designing a research study or considering changes to a patient's medication therapy based on published research, pharmacists must be knowledgeable about potential sources of bias in clinical research and how these threats to internal validity can be mitigated.
Gary L. Cochran+2 more
wiley +1 more source
Neuroimaging markers of intracranial hypertension in cerebral venous thrombosis: A systematic review and meta-analysis. [PDF]
Aleid AM+9 more
europepmc +1 more source
The Thrombolytic Activities In A Rabbit Model Of Venous Thrombosis Of An Acyl Human Plasmin Derivative (BRL 26920) And An Acyl Streptokinase Human Plasminogen Activator Complex (Brl 26921) [PDF]
R J Dupe+3 more
openalex +1 more source
The relationship between Cytochrome P450 2C19 (CYP2C19) polymorphisms and coronary artery disease (CAD) in hypertensive patients was analyzed. CYP2C19 loss‐of‐function, BMI ≥ 24.0 kg/m2, and history of alcoholism were independent risk factors for CAD in hypertensive patients.
Guoliang Wei+10 more
wiley +1 more source
Pulmonary embolism and deep venous thrombosis [PDF]
Anthony J. Comerota
openalex +1 more source
POCUS‐guided peripheral intravenous (PIV) access significantly improves success rates in patients with difficult venous access. This technique leads to higher first‐attempt success, fewer attempts, shorter procedure times, and reduced complications compared to standard methods, making it a safer and more efficient option for challenging cases ...
Hany A. Zaki+6 more
wiley +1 more source
Endovascular treatment for cerebral venous thrombosis: a multicenter study in China. [PDF]
Bian HT+41 more
europepmc +1 more source